ערך בספרים למניה: Liquidia Corporation (LQDA)

Liquidia Corporation (LQDA) management demonstrates high proficiency in patent legal defense and market entry preparation, as evidenced by the stock quotes shown on this chart. The business relies on unique drug delivery methods via specialized inhalers, creating an indispensable therapeutic cycle. Meanwhile, the current figure stands at 2.17, as the R&D stage and legal expenses temporarily constrain operational efficiency until mass sales commence.

For a conservative investor, this indicator serves as a measure of the real value of net assets. Amid patent wars, Liquidia Corporation (LQDA) capital acts as a survival guarantee during protracted legal disputes. By analyzing the projected book value per share on GURU.Markets, an investor sees the remaining equity after deducting all liabilities. Growth in this metric confirms resilience to regulatory shocks, while a stable trend signals the issuer's continued solvency.